Press Release Alzheimer’s Association, Individuals Living with Alzheimer’s Urge FDA to Grant Traditional Approval for Lecanemab Read Press Release
Press Release Alzheimer’s Advocate Testifies What Access to FDA-Approved Alzheimer’s Treatments Means Read Press Release
Press Release Alzheimer’s Association Statement on Donanemab Phase 3 Topline Data Release Read Press Release
